All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
Now you can personalise
your GvHD Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for youFind out more
Bookmark this article
During the GvHD Hub Steering Committee meeting on April 5, 2022, key opinion leaders met to debate how duration of response should be defined. The recorded discussion was chaired by Mohamad Mohty and featured Amin Alousi, Ali Bazarbachi, Hildegard Greinix, and Attilio Olivieri.
How should duration of response be defined?
Mohty begins by stating that it is only recently, with the approval of agents for GvHD treatment, that the question of how to define response has become a concern. Bazarbachi discusses the importance of achieving an ongoing response rather than a transient one to improve outcomes in acute GvHD. The steering committee contemplate how the side effects of treatment can result in early initiation of the next line of therapy, and the impact of organ damage on response definition is also considered.
ASH 2023 abstracts: What’s hot in GvHD?
To help navigate the exciting content presented at the 65th ASH Annual Meeting, the GvHD Hub Steering Committee members provided their recommendations for the top presented abstracts in GvHD.
How should novel agents be used in the current treatment pathways for GvHD?
During the GvHD Hub Steering Committee meeting on April 5, 2022, key opinion leaders met to debate the question of how novel agents should be used in the current treatment...
Subscribe to get the best content related to GvHD delivered to your inbox